Aperio Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$21.8M Buy
76,873
+7,939
+12% +$2.25M 0.06% 294
2020
Q3
$19M Buy
68,934
+10,461
+18% +$2.88M 0.06% 281
2020
Q2
$13.3M Buy
58,473
+9,646
+20% +$2.19M 0.05% 369
2020
Q1
$7.43M Buy
48,827
+6,662
+16% +$1.01M 0.03% 514
2019
Q4
$6.34M Sell
42,165
-1,795
-4% -$270K 0.02% 651
2019
Q3
$6.24M Sell
43,960
-916
-2% -$130K 0.02% 633
2019
Q2
$5.62M Buy
44,876
+955
+2% +$120K 0.02% 671
2019
Q1
$4.84M Sell
43,921
-283
-0.6% -$31.2K 0.02% 714
2018
Q4
$4.33M Sell
44,204
-106
-0.2% -$10.4K 0.02% 693
2018
Q3
$5.47M Sell
44,310
-219
-0.5% -$27K 0.02% 649
2018
Q2
$4.42M Sell
44,529
-460
-1% -$45.7K 0.02% 713
2018
Q1
$3.97M Buy
44,989
+978
+2% +$86.3K 0.02% 738
2017
Q4
$4.34M Sell
44,011
-354
-0.8% -$34.9K 0.02% 688
2017
Q3
$4.27M Sell
44,365
-863
-2% -$83.1K 0.02% 659
2017
Q2
$4.28M Buy
45,228
+14,632
+48% +$1.38M 0.03% 650
2017
Q1
$2.5M Buy
30,596
+1,877
+7% +$153K 0.02% 795
2016
Q4
$2.44M Sell
28,719
-1,516
-5% -$129K 0.02% 752
2016
Q3
$2.25M Buy
30,235
+3,831
+15% +$285K 0.02% 798
2016
Q2
$2M Buy
26,404
+896
+4% +$68K 0.02% 807
2016
Q1
$1.77M Buy
25,508
+1,873
+8% +$130K 0.02% 825
2015
Q4
$1.42M Buy
23,635
+729
+3% +$43.9K 0.01% 876
2015
Q3
$1.24M Sell
22,906
-497
-2% -$26.9K 0.01% 895
2015
Q2
$1.36M Buy
23,403
+803
+4% +$46.6K 0.01% 852
2015
Q1
$1.36M Buy
22,600
+1,693
+8% +$102K 0.02% 827
2014
Q4
$1.11M Buy
20,907
+4,442
+27% +$236K 0.01% 859
2014
Q3
$737K Sell
16,465
-144
-0.9% -$6.45K 0.01% 972
2014
Q2
$701K Buy
16,609
+4,424
+36% +$187K 0.01% 986
2014
Q1
$537K Buy
+12,185
New +$537K 0.01% 1298
2013
Q4
Sell
-9,200
Closed -$379K 1230
2013
Q3
$379K Buy
9,200
+1,326
+17% +$54.6K 0.01% 1287
2013
Q2
$277K Buy
+7,874
New +$277K 0.01% 1320